Penumbra Promotes Shruthi Narayan to President

Penumbra has promoted Shruthi Narayan to President of the company, effective on September 1, 2025.

Narayan will continue to report to Adam Elsesser, who was President before this promotion and will continue in his roles as chairman of the board and CEO of Penumbra.

She was most recently president of Penumbra’s interventional business, where she led day-to-day operations and oversaw growth initiatives of both the company’s neuro and vascular franchises. Narayan joined Penumbra in 2013 as a product manager starting on the stroke franchise, then transitioning to help build the vascular division.

She began her medical device career at Medtronic in 2006, working in engineering, regulatory affairs, then in the cardiovascular sales organization.

“Shruthi is a dynamic, seasoned leader whose passion for innovation and proven ability to inspire global teams make her the obvious choice for this critical role,” said Elsesser. “Her vision and focus on excellence will undoubtedly help sustain Penumbra’s exceptional growth and market leadership, expanding access to our life-saving technology to patients around the world.”

In October 2024, the company secured a CE mark for its latest computer assisted vacuum thrombectomy (CAVT) technologies—Lightning Flash 2.0 and Lightning Bolt 7.

“Penumbra has been at the forefront of blood clot care for more than 20 years, advancing the most innovative technologies to address conditions from head-to-toe like stroke and pulmonary embolism,” said Narayan. “I am honored to carry on and expand our legacy of innovation and look forward to continuing this paradigm shift in patient care.”